Perspective Therapeutics (CATX) Non Operating Income (2010 - 2026)

Perspective Therapeutics has disclosed Non Operating Income across 17 years of filings, most recently posting $2.1 million for Q1 2026.

• Non Operating Income for Q1 2026 came in at $2.1 million, down 42.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.6 million (down 41.45% YoY), and the FY2025 annual result was $9.1 million, down 12.65% from the prior year.
• Non Operating Income came in at $2.1 million for Q1 2026 at Perspective Therapeutics, up from $1.5 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $3.7 million in Q1 2025 to a low of $28000.0 in Q2 2022.
• The 5-year median for Non Operating Income is $1.2 million (2024), against an average of $1.4 million.
• Across the five-year window, Non Operating Income plunged 94.12% in 2023 and surged 8136.36% in 2024, its largest moves.
• Perspective Therapeutics' Non Operating Income stood at $561000.0 in 2022, then slumped by 94.12% to $33000.0 in 2023, then soared by 8136.36% to $2.7 million in 2024, then tumbled by 43.01% to $1.5 million in 2025, then surged by 35.05% to $2.1 million in 2026.
• The last three Non Operating Income figures came in at $2.1 million (Q1 2026), $1.5 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.